Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Depreciation & Amortization (CF) (2017 - 2026)

Updated

Crinetics Pharmaceuticals (CRNX) reported Depreciation & Amortization (CF) of $1.07 million for Q2 2026, up 11.9% from $959,000 a year earlier but down 7.5% from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Crinetics Pharmaceuticals' Depreciation & Amortization (CF) came in at $4.24 million, up 23.2% year-over-year; for FY2025, it was $3.89 million, up 39.7% from FY2024.

  • Depreciation & Amortization (CF) has increased for four consecutive years, with a five-year compound annual growth rate of 32.6% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $2.79 million in FY2024 (+153.6%), $1.1 million in FY2023 (+11.7%), $983,000 in FY2022 (+6.6%) and $922,000 in FY2021 (-2.7%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $215,000 in Q2 2022 and a high of $1.16 million in Q1 2026.
  • Year over year, Depreciation & Amortization (CF) has now increased in each of the last ten quarters, with growth averaging 75.0% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q4 2024 (growth of 200.8%); the low point was Q2 2022 (a decline of 6.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.16 million (Q1 2026), $994,000 (Q4 2025) and $1.01 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn 1.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.07 Mn
Mar 31, 2026 1.16 Mn
Dec 31, 2025 994,000.00
Sep 30, 2025 1.01 Mn
Jun 30, 2025 959,000.00
Mar 31, 2025 925,000.00
Dec 31, 2024 788,000.00
Sep 30, 2024 770,000.00
Jun 30, 2024 753,000.00
Mar 31, 2024 474,000.00
Dec 31, 2023 262,000.00
Sep 30, 2023 273,000.00
Jun 30, 2023 280,000.00
Mar 31, 2023 283,000.00
Dec 31, 2022 280,000.00
Sep 30, 2022 248,000.00
Jun 30, 2022 215,000.00
Mar 31, 2022 240,000.00
Dec 31, 2021 235,000.00
Sep 30, 2021 233,000.00
API Access

Crinetics Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CRNX&period=max&api_key=YOUR_API_KEY